STAT 3 |
Transcriptional factor, activation of the MAP kinase |
Bone turnover |
Itoh et al. [27] |
HOXA 10 |
Activation of Runx2, alkaline phosphatase, osteocalcin, and bone sialoprotein |
Osteogenic response |
Hassan et al. [25] |
AKT1 |
Suppression of osteoblasts apoptosis through inhibition of Fox03a and Bim; Mediation of the osteoblastic bone formation by IGF-1 and insulin. |
Bone formation |
Kawamura et al. [29] |
CALM1 |
Signal transduction, stimuli to proliferation |
Bone formation |
Rhymer et al. [40] |
P2RX7 |
Activation of P2RX7 receptors stimulates expression of osteoblast markers and enhances mineralization in cultures cells |
Promote osteogenesis |
Ohlendorff et al. [37] |
FN1 |
Adhesion and migration cellular process |
Extracellular matrix stability; tissue healing |
Potts and Campbell [39] |
COL1A2 |
Collagen 1α2, chain of the most abundant collagen in the human organism |
Extracellular matrix stability |
Antoniv et al. [6] |
SPARC |
The most abundant noncollagenous protein in the bone tissue. |
Modulation of the cell-matrix interaction and production of the matrix |
Yan and Sage [47] |
VCL |
Associated with the intercellular junctions between the cells and the matrix |
Anchorages the actin to the cellular membrane |
Ziegler et al. [49] |
TIMP1 |
Inhibits collagen and other components of extracellular matrix degradation operated by the metalloproteinase |
Decrease matrix degradation |
Hatori et al. [26] |